Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hepatitis

Free Subscription 26.05.2025 1 Ann Intern Med 1 BMC Pediatr 2 Clin Infect Dis 4 Hepatology 2 J Hepatol 4 J Med Virol 1 J Viral Hepat 3 PLoS One 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. PIRZADA SA, Sherker AH
   Guideline recommends antiviral prophylaxis for patients at high risk for HBV reactivation.
   Ann Intern Med. 2025;178:JC50.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

2. MOHAMMED O, Efua SV, Adjei CA, Darkwa IO, et al
   Uptake of combined immunoprophylaxis for newborns exposed to hepatitis B virus in a high hepatitis B endemic rural setting in Northern Ghana.
   BMC Pediatr. 2025;25:407.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

3. HALL EW, Sandul AL, Kamili S, Cartwright EJ, et al
   Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C Among US Adults.
   Clin Infect Dis. 2025 May 21:ciaf166. doi: 10.1093.
   PubMed         Abstract available
   
   
4. KU JH, Gu YM, Hoke CF, Tseng HF, et al
   Screening and vaccination rates for tetanus, hepatitis A, and hepatitis B among individuals with substance use disorders who are hospitalized in an integrated U.S. health system.
   Clin Infect Dis. 2025 May 20:ciaf251. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Hepatology

5. KILANY MM, Sonneveld MJ, Feld JJ, Janssen HLA, et al
   Management of Immune Tolerant Chronic Hepatitis B.
   Hepatology. 2025 May 20. doi: 10.1097/HEP.0000000000001407.
   PubMed         Abstract available
   
   
6. MACHIDA K, Tsukamoto H, Liu JC, Han YP, et al
   Retraction: C-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair.
   Hepatology. 2025;81:E181.
   PubMed        
   
   
7. OZMERT EH
   Infliximab to the rescue: Autoimmune hepatitis meets its match.
   Hepatology. 2025;81:1621-1622.
   PubMed        
   
   
8. LYU X, Sze KM, Lee JM, Husain A, et al
   Disparity landscapes of viral-induced structural variations in hepatocellular carcinoma: Mechanistic characterization and functional implications.
   Hepatology. 2024 Sep 13. doi: 10.1097/HEP.0000000000001087.
   PubMed         Abstract available
   
   

   
   J Hepatol

9. BOZWARD AG, Davies SP, Morris SM, Kayani K, et al
   Cellular interactions in self-directed immune-mediated liver diseases.
   J Hepatol. 2025;82:1110-1124.
   PubMed         Abstract available
   
   
10. DEGASPERI E, Anolli MP, Jachs M, Reiberger T, et al
    Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis.
    J Hepatol. 2025 Jan 8:S0168-8278(25)00001-7. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available
    
    

    
    J Med Virol

11. YOU Q, Wang K, Zhao Z, Zhou H, et al
    Reduction of Bacteroides fragilis in Gut Microbiome of Chronic Hepatitis B Patients Promotes Liver Injury.
    J Med Virol. 2025;97:e70395.
    PubMed         Abstract available
    
    
12. ELIZALDE MM, Monzani MC, Favale NO, Bouzas B, et al
    Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions in the HBeAg-Negative Stage of Chronic Hepatitis B.
    J Med Virol. 2025;97:e70398.
    PubMed         Abstract available
    
    
13. SANTOS-SILVA S, Lois M, Machado A, Bordalo A, et al
    Environmental Surveillance of Hepatitis E Virus and Rat Hepatitis E Virus in Portugal and Spain, 2020-2022.
    J Med Virol. 2025;97:e70414.
    PubMed         Abstract available
    
    
14. MAO T, Du X, Li Y, Zhou Z, et al
    DNAJC9 Binds to and Enhances the Transcription of Hepatitis B Virus cccDNA by Recruiting Histone H3.3.
    J Med Virol. 2025;97:e70390.
    PubMed         Abstract available
    
    

    
    J Viral Hepat

15. SI NAFA SA, Benali S, Penaranda G, Deuffic-Burban S, et al
    Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good Option! The DEVICHO Study.
    J Viral Hepat. 2025;32:e70038.
    PubMed         Abstract available
    
    

    
    PLoS One

16. BAHARUDIN MH, Mokhtar SA, Azman AZF, Mohd Nazan AIN, et al
    Utilizing Theory of Planned Behaviour to increase intention to participate in hepatitis C treatment therapy among Methadone maintenance therapy clients (MMT) in Malaysia: A cluster randomised control trial.
    PLoS One. 2025;20:e0324718.
    PubMed         Abstract available
    
    
17. SEGHIERI C, Ceccarelli L, Tortu C, Tavoschi L, et al
    Evaluating the effectiveness of a population-level health intervention to increment HCV treatment coverage in tuscany region, Italy: An interrupted time series analysis.
    PLoS One. 2025;20:e0306733.
    PubMed         Abstract available
    
    
18. CAM HUONG NT, Van Tri D, Luan NH, Thinh NH, et al
    Seroprevalence of hepatitis A virus infection in urban and rural areas in Vietnam.
    PLoS One. 2025;20:e0323139.
    PubMed         Abstract available
    
    

    
    Vaccine

19. HUNG SH, Torres JL, Chen F, Giang E, et al
    Antigenic and EM characterization of the Chiron experimental hepatitis C virus vaccine.
    Vaccine. 2025;58:127239.
    PubMed         Abstract available
    
    

    
    Virology

20. PFEFFERKORN M, Brehm J, Brehm M, Honshoven F, et al
    Overrange dilution for improvement of hepatitis B core related antigen as a biomarker: protocol validation and examples for application.
    Virology. 2025;609:110576.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.